ARTS AND HUMANITIES RESEARCH COUNCIL
Research Grants
- Award winner: Duncan Pritchard
- Institution: University of Edinburgh
- Value: £404,685
Extended knowledge
- Award winner: Neil Sinclair
- Institution: University of Nottingham
- Value: £103,531
From explanation to ethics and back again
- Award winner: Naomi Sakr
- Institution: University of Westminster
- Value: £424,109
Orientations in the development of Pan-Arab television for children
LEVERHULME TRUST
Research Project Grants
Sciences
- Award winner: Dek Woolfson
- Institution: University of Bristol
- Value: £143,611
The design, assembly and functionalisation of peptide nanotubes
- Award winner: Joseph Jackson
- Institution: Aberystwyth University
- Value: £242,019
Thermal variation and immunity in ectothermic vertebrates
- Award winner: Eric Barnard
- Institution: University of Cambridge
- Value: £74,598
Assemblies and migrations of native P2Y ATP-receptors in the developing brain
ECONOMIC AND SOCIAL RESEARCH COUNCIL
Research Seminar Awards
Political science and international studies
- Award winner: Adam Quinn
- Institution: University of Birmingham
- Value: £17,575
The future of American power
Social policy
- Award winner: Joanna Richardson
- Institution: De Montfort University
- Value: £14,694
Creating space and place for Roma, gypsies and travellers: resolving conflict
- Award winner: Alex Nicholls
- Institution: University of Oxford
- Value: £14,807
Reconstructing social enterprise
- Award winner: Christina Victor
- Institution: Brunel University
- Value: £17,950
Ageing, race and ethnicity
- Award winner: Lesley Hoggart
- Institution: University of Greenwich
- Value: £13,513
Understandings of the young sexual body
IN DETAIL
National Institute for Health Research
Award winner: David Fitzmaurice
Institution: University of Birmingham
Value: £226,482
The development and evaluation of a prognostic model and clinical decision rule to help decide on cessation of anticoagulant therapy in patients with idiopathic venous thromboembolism (VTE)
This project aims to provide a rule that can identify patients who have suffered embolisms but who are at very low risk of further blood clots in either their legs or lungs. At the moment patients who suffer blood clots in these areas are treated for three to 12 months with oral anticoagulants because doctors are unsure about how long they should be treated. Lengthy treatment can cause problems, however, and some patients will develop further clots however long they are treated. It is important therefore that doctors are able to identify patients for whom it is safe to stop after routine treatment so that they can concentrate resources on those who need it. The study will utilise a large database of information to try to formulate the rule.